A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma
Theo S. Plantinga(Genmab (Netherlands)), Romana T. Netea‐Maier(Radboud University Nijmegen)
Cited by 37
Related Papers
Integration of multi-omics data and deep phenotyping enables prediction of cytokine responses
|Nature Immunology|2018|157
Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC
|European Journal of Clinical Microbiology & Infectious Diseases|2016|73
Integration of metabolomics, genomics, and immune phenotypes reveals the causal roles of metabolites in disease
|Genome biology|2021|69
Thyrotrophin and thyroxine support immune homeostasis in humans
|Immunology|2021|29